Concordia Healthcare acquires legacy pharmaceutical products and acquires and develops orphan drugs.
Concordia is focused on acquiring Specialty Healthcare and Pharmaceutical Distribution companies.
Concordia trades on the NASDAQ Global Select Market® under the symbol CXRX, and on the Toronto Stock Exchange under the symbol CXR.
May 13, 2016
First quarter 2016 revenue of $228.5 million, an increase of 19 per cent over the fourth quarter of 2015 ...
April 29, 2016
OAKVILLE, ON, April 29, 2016 /CNW/ – Concordia Healthcare Corp. (“Concordia” or the ...